This chronic chagasic cardiomyopathy could arise as a result of parasite-induced autoimmune response, as suggested by several experimental evidences, i.e., the very low levels of tissue parasites at this stage of the disease (3), the presence of anti-myocardial antibodies (4, 5) , the presence of myocardial, muscle, and nerve lymphomononuclear cell infiltrates (6, 7) , and abnormalities in circulating lymphocyte subpopulations (8, 9), thus indicating that Chagas' disease courses with multiple immunological abnormalities involving both humoral and cellular immune responses.
Among the antimyocardial antibodies, we have described the presence of antibodies in human and murine chagasic sera that trigger neurotransmitter receptor-mediated biological effects. This has a variety of functional consequences in myocardial activity (10-12), such as alterations in the physiology and biochemistry of myocardium leading to dysautonomia. These biological effects could play some role in the pathogenesis of the chronic chagasic myocardiopathy (10). It has been suggested that antigens shared by T. cruzi and the host could be involved in the onset of chronic Chagas' disease (13, 14) . Some homologous antigens between T. cruzi and mammals such as some ribosomal proteins (15) , laminin (16) , tubulin (17, 18), a muscle sarcoplasmic antigen (19), and some antigens of the nervous system (20,21) have been described. Antibodies against these antigens have been found in the serum of individuals with Chagas' disease (15, 16, 21 ).
We have previously described a lytic monoclonal antibody (MAb CAK2O.12) that recognizes a 150 kDa antigen in T.
cruzi and also reacts with normal human striated muscle tissue and with normal murine smooth and striated muscle of tissues affected in chronic Chagas' disease (22 However, the inhibitory effect of the antibody is higher on -adrenoceptors than on mAChR radioligand binding.
The saturation studies and Scatchard plots indicated that the inhibition was essentially due to a decrease in the number of binding sites (B15), with no significant changes in the equilibrium constant K(l (Fig. 3A and Fig. 3B) . Therefore, MAb CAK2O. 12 affected the specific radioligand binding in a noncompetitive fashion. 4A ). When the sympathetic action of MAb CAK2O.12 was abrogated by pretreating the atria with propranolol, an increase in atria cGMP level was observed (Fig. 4B) . This stimulatory effect was abolished by atropine at 5 x 1O M, pointing to a muscarinic cholinergic receptor involvement in the interaction of MAb CAK2O.12 with cardiac tissue (Fig.  4B) .
Mechanical activity of isolated atria
The ability of MAb CAK2O.12 to induce a change in contractility (dF/dt) is shown in Fig. 5 . It can be seen that the MAb was able to increase the dF/dt (Fig. 5A) and to decrease the frequency ofcontraction (Fig. 5B) ones for binding inhibition and intracellular messengers production. The isotype-matched negative control MAb BI24 has no effect either on dF/dt (g/s basal: 3.9 ± 0.2; MAb B124: 4.2 ± 0.4, n = 5) or on frequency (beats/mm basal: 165 ± 8; MAb B124: 163 ± 7; n = 5). Preincubation of atria with the 3-adrenergic blocker propranolol
(1 x iO M) blunted the positive inotropism and potentiated the negative chronotropism elicited by MAb CAK2O.12. In contrast, after incubalion with the muscarinic blocker atropine (1 x iO M), the negative chronotropism was inhibited and the positive inotropism was potentiated (Fig. 5) . These results show that the increment of dF/dt is associated to the activation of t3-adrenoceptors, whereas the decrement of frequency is related to muscarinic cholinergic receptoractivation.
DISCUSSION
Chronic Chagas' heart disease is a cardioneuromyopathy in which the sympathetic and parasympathetic nervous systems are affected (32-34). This dysautonomia has been partially explained by a slow and progressive blockade of neurotransmitterreceptors (34). It has been suggested that the damage to the heart and to the autonomic nervous system could be a consequence of an autoimmune response to cross-reactive antigens between T. cruzi and host tissues (molecular mimicry; [13] [14] [15] 35 ). However, the mechanisms involved in the pathogenesis of Chagas' cardiac neuromyopathy have not been yet established.
We analyzed the effects of an anti-T. cruzi MAb on the physiology and biochemistry of normal myocardium and we paralleled these actions with those induced by circulating antibodies present in human and mouse chagasic sera on the same tissue.
The anti-T. cruzi MAb used in this work, CAK2O.12 (IgG2b), was derived from a mouse chronically infected with the k98 clone of the CA1 strain of T. cruzi. This MAb recognizes a 150 kDa surface antigen, widely distributed among strains ofT. cruzi (22). We have special interest in using this MAb for three reasons: 1) CAK2O.12 recognizes an epitope present in striated muscle of syngeneic mice (22); 2) sera from patients infected with T. cruzi (100% of patients with chronic and 85% of patients with acute Chagas' disease) present specific IgG to the antigen recognized by MAb CAK2O.12 (22); and 3) the infective myotropic strain used for the production of CAK2O.12 induces in BALB/c-infected mice specific antibodies proved to activate both f-adrenoceptors and mAChR in normal murine myocardium (12).
MAb CAK2O. 12 binds to membranes of heart and ventricle from normal syngeneic mice, as shown by dot-blot (Fig. 1) . The slight nonspecific reactivity detected with MAb B124 (negative control) could be due to the presence of normal mouse IgG in the preparation reacting with the secondary antibody (anti-mouse IgG labeled with peroxidase).
Furthermore, binding of the f-adrenoceptor radioligand [1251]CYP 4.
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1.. BALB/c hearts or auricleswere incubated alone or with 1 x iO M of normal IgG (unfilled bar) or MAb CAK2O.12 (black) for 5 mm in the absence or in the presence of 5 x i0 M of propranolol(diagonalstripes), 5 x iO M of atropine (shaded), or both (cross-hatched), and intracellular levels of cyclic nucleotides were measured in tissue homogenate residues as described in Materials and Methods. Results are expressed as the mean pmol/wet weight ± smamof three independent experiments performed in triplicate.
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*Differ significantly from basal values with P < 0.01, according to the Dunnet's test.
and of the mAChR radioligand [3H]QNB were inhibited in a dose-dependent manner by MAb CAK2O. 12 upon interaction with cardiac membranes. This inhibition appears to be noncompetitive (decrement the number of binding sites without modification of theKd). f3-Adrenergic receptor activation leads to the activation of the adenylate cyclase (a.c.) system inducing the production of the second messenger cAMP (36) whereas mAChR triggers the production of cGMP and the inhibition of the a.c. system, among otherbiochemical intracellular pathways (37). After MAb's interaction with cardiac tissue, both -adrenergic receptors and mAChR were activated. MAb CAK2O.12 induced an increase in intracellular cAMP levels through the activation of cardiac f3-adrenoceptors as it was blocked by propranolol; this effect was potentiated by atropine that impaired the mAChR-mediated inhibition of the a. 39, [1861] [1862] [1863] [1864] [1865] [1866] [1867] [1868] 28. Cremaschi,C., Corelik, C., Cenaro, A., Borda,E.,and Sterin-Bortla. L. 
